Article
type: Class

Document
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Inglese
type: Language

Entity
type: Class

Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real-Life Multicenter Experience. Results From the REDOT_MCL Study
type: Academic Article
type: Document
type: Thing
language: Inglese
type: Entity
type: Generically Dependent Continuant
most specific type: Academic Article
type: Article
type: Information Content Entity
type: Continuant

Generically Dependent Continuant
type: Class

individual
rights: termsOfUse
date: 2026-08-25T22:11:02
publisher: Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real-Life Multicenter Experience. Results From the REDOT_MCL Study
type: Document
label: RDF description of Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real-Life Multicenter Experience. Results From the REDOT_MCL Study - http://irises.unibs.it/resource/item/260339